ALKS Reports $392.9M Revenue, $66.5M GAAP Loss, $80.3M Adjusted EBITDA, Acquires Avadel for $775M Cash, Repurchases $28M Shares
Alkermes Inc. plc · PHARMACEUTICAL PREPARATIONS · Now $42.19
+5.8% in 7d after detection
Post-detection moves
1h
—
1d
-2.6%
3d
-3.5%
7d
+5.8%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS